HCA Maintained by TD Cowen -- Price Target Raised to $486

gurufocus.com · 2026-10-28

HCA Healthcare Analyst Rating Update On October 12, 2023, TD Cowen maintained a Buy rating for HCA Healthcare (HCA) while raising the price target from $460.

TickrTrends take: TD Cowen raised its price target for HCA Healthcare to $486 while maintaining its rating on the stock. Given TickrTrends' current assessment that HCA is fairly valued, investors monitoring the company should observe whether this elevated price target reflects confidence in near-term earnings growth or represents upside potential relative to current market pricing. The maintained rating combined with a higher price target suggests analyst confidence in the Healthcare sector company's fundamentals, though valuation-focused readers will want to track whether the stock moves toward the new target or if the fair value assessment shifts accordingly.

Read the full story at gurufocus.com →